Newstral
Article
wsj.com on 2015-06-17 13:21
Botox Owner Allergan to Buy Maker of Double-Chin Treatment
Related news
- Botox maker Allergan buying Kythera, developer of double chin treatmentLA Times
- Botox maker Allergan adds 'double-chin' drug in $2.1B buydothaneagle.com
- Botox maker Allergan adds ‘double-chin’ drug in $2.1B buyThe Findlay Courier
- Botox maker Allergan adds 'double-chin' drug with $2.1B dealabqjournal.com
- AbbVie makes $63B bid for Botox maker AllerganThe Fresno Bee
- HAbbVie Makes $63B Bid for Botox Maker Allerganhamodia.com
- AbbVie to buy Botox maker Allergan in $63-billion dealbusiness.financialpost.com
- Carl Icahn buys stake in Botox-maker AllerganThe Salt Lake Tribune